- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04105790
The Acceptability and Effectiveness of Stepped Care Psychoeducation Classes in Rural Manitoba
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will evaluate the acceptability and effectiveness of class-based psychoeducation as the first step of a stepped care model in a community mental health program. In April of 2019, the Prairie Mountain Health (PMH) Adult Community Mental Health programs (both Northern and Southern regions) instituted a change to their existing service model. Previously, all individuals who sought access to public mental health services underwent an intake interview and were subsequently assigned a community mental health worker (CMHW) with whom they met for individual counselling. Due to the ever-increasing demand for services, CMHWs were required to manage large caseloads which resulted in extended periods between counselling appointments and strain on care providers. In an effort to introduce a stepped-care framework to mitigate workload, the Adult Community Mental Health programs in PMH North and South began to offer psychology-led psychoeducation classes as a step below individual counselling. Specifically, the Cognitive Behavioural Therapy with Mindfulness (CBTm) classes, developed at the University of Manitoba by Sareen, Sala, Wong, Whitney, and Kinley (2016), were delivered. This program is comprised of four 90-minute sessions that deliver information about basic cognitive and behavioural therapy principles and effective self-help resources. It was developed to offer services to clients on the waitlist for outpatient mental health services in Winnipeg and preliminary research on this program has demonstrated that it is an acceptable form of treatment and effectively reduces symptoms of anxiety and depression (with a small to medium effect).
As the change in the service delivery model and the introduction of large psychoeducation classes in PMH's Adult Community Mental Health programs is novel, evaluation of this change is warranted. This study will examine foundational program variables including retention, acceptability, and effectiveness (see Thakur, Bolton, & Sareen, 2018). Assessing these factors will provide critical information about the potential for further development of a stepped care model, including the CBTm program, in this rural health region and afford the opportunity to compare outcome measures in a rural setting to those from an urban centre (data published by Thakur et al., 2018). In order to further increase access to services, the program was also intended to be delivered to remote rural sites via telehealth; exploration of the acceptability and efficacy of telehealth use in service delivery also merits assessment. However, at the start of the COVID-19 pandemic, in-person and MBTelehealth CBTm classes were suspended to abide by provincial physical distancing guidelines. Moving forward, the CBTm classes will be offered via MS Teams, a virtual videoconferencing platform for all attendees, allowing individuals to participate via videoconference or telephone from their preferred location within Manitoba.
The research questions and hypotheses are as follows:
- Is the implementation of CBTm as the first step in a stepped model acceptable to rural clients? The investigators hypothesize that class-based clinical service will be acceptable to rural clients as it will increase their access to valuable mental health services in their region; this will be demonstrated in a high rate of retention and positive feedback from participants.
- How are issues unique to rural settings, such as concerns about confidentiality and virtual delivery of programming, in a class-based setting viewed by rural clients? The investigators anticipate initial concerns about confidentiality and virtual service delivery related to the nature of the rural setting.
- Are class-based clinical services (i.e., CBTm) effective for reducing symptoms of depression and anxiety for participants living in rural areas? Consistent with previous research, the investigators anticipate a small to medium effect size in the decrease of symptoms of depression and anxiety and increased incorporation of cognitive behavioural strategies into daily life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Brandon, Manitoba, Canada, R7A 6N5
- Prairie Mountain Health South - Adult Community Mental Health
-
Dauphin, Manitoba, Canada, R7N 1R7
- Prairie Mountain Health North - Community Mental Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult clients (18+ years) accessing community mental health services for symptoms of depression and anxiety, and
- Interest in attending Cognitive Behaviour Therapy with Mindfulness classes.
Exclusion Criteria:
- Active psychosis or mania,
- Acutely elevated suicide risk,
- Severe cognitive impairment, and/or
- Non-English speaking.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Participants
Participants in class-based mental health intervention.
|
The standard CBTm protocol is comprised of four 90-minute classes offered virtually via videoconferencing once a week for four consecutive weeks.
The classes cover topics including mindfulness, cognitive therapy principles, behaviour therapy principles, managing anger, assertiveness, problem solving, goal setting, and evidence-based self-help resources.
They are lecture-based but also involve experiential elements, such as mindfulness activities and practice of cognitive therapy strategies.
Participants are assigned daily homework between each class to practice the strategies taught in session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Change measure (baseline, week 2, week 3, and week 4)
|
Self-report measure of severity of depressive symptoms to be completed prior to each intervention class.
Each of the 9 items is scored 0-3 (0 = not at all; 3 = nearly every day), yielding a total between 0 and 27, with higher scores representing increased severity of depression symptoms.
|
Change measure (baseline, week 2, week 3, and week 4)
|
|
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: Change measure (baseline, week 2, week 3, and week 4)
|
Self-report measure of severity of generalized anxiety symptoms to be completed prior to each intervention class.
Each of the 7 items is scored 0-3 (0 = not at all; 3 = nearly every day), yielding a total between 0 and 21, with higher scores representing increased severity of generalized anxiety symptoms.
|
Change measure (baseline, week 2, week 3, and week 4)
|
|
Acceptability Survey
Time Frame: Change measure (baseline and week 4)
|
Self-report measure of the acceptability of different elements of the intervention to be completed prior to the first and fourth classes.
|
Change measure (baseline and week 4)
|
|
Class Evaluation Form
Time Frame: Data collected weekly throughout the four weeks of study enrolment
|
Self-report measure of the acceptability of different elements of the intervention to be completed prior to the first and fourth intervention classes.
|
Data collected weekly throughout the four weeks of study enrolment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Global Impression scale (CGI)
Time Frame: Change measure (baseline at week 2, week 3, and week 4)
|
Self-report measure of improvement in symptoms to be completed prior to intervention classes 2, 3 and 4. The single item is scored 1-7 (1 = very much improved; 7 = very much worse), yielding a total between 1 and 7, with higher scores representing a worsening of symptoms.
|
Change measure (baseline at week 2, week 3, and week 4)
|
|
Cognitive Behaviour Therapy Skills Questionnaire (CBTSQ)
Time Frame: Change measure (baseline, week 2, week 3, and week 4)
|
Self-report measure of the extent of participants' learning and implementation of cognitive and behavioural coping skills to be completed prior to each intervention class.
Each of the 16 items is scored 1-5 (1 = I don't do this; 5 = I always do this).
The measure is comprised of two subscales, (1) Behavioural Activation (7 questions) and (2) Cognitive Restructuring (9 questions); item scores are summed to yield subscale scores, with higher scores indicating increased implementation of the respective subscale skills.
The two subscales can be summed to create a total score, yielding a total between 16 and 80, with higher scores representing increased implementation of both sets of skills.
|
Change measure (baseline, week 2, week 3, and week 4)
|
|
Treatment Acceptability/Adherence Scale (TAAS)
Time Frame: Change measure (baseline, week 2, week 3, and week 4)
|
Self-report measure related to perceptions of the therapy and participants' ability to engage in the skills taught during the class to be completed prior to intervention classes 2, 3, and 4. Each of the 10 items is scored from 1-7 (1 = disagree strongly; 7 = agree strongly), yielding a total between 10 and 70, with higher scores representing positive perceptions of treatment acceptability and adherence.
|
Change measure (baseline, week 2, week 3, and week 4)
|
|
Homework Record
Time Frame: Data collected weekly throughout the four weeks of study enrolment
|
Self-report measure of homework completion and skills practice to be completed prior to intervention classes 2, 3 and 4.
|
Data collected weekly throughout the four weeks of study enrolment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pamela Black, PhD, University of Manitoba
Publications and helpful links
General Publications
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
- Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092.
- Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul;4(7):28-37.
- Milosevic I, Levy HC, Alcolado GM, Radomsky AS. The Treatment Acceptability/Adherence Scale: Moving Beyond the Assessment of Treatment Effectiveness. Cogn Behav Ther. 2015;44(6):456-69. doi: 10.1080/16506073.2015.1053407. Epub 2015 Jun 19.
- Sareen, J., Sala, T., Wong, J., Whitney, D., & Kinley, J. (2016). CBTm facilitator training manual. Retrieved from http://cbtm.ca/wp-content/uploads/2017/08/Facilitators_binder.pdf
- Thakur VK, Wong JY, Randall JR, Bolton JM, Parikh SV, Mota N, Whitney D, Palay J, Kinley J, Diocee S, Sala T, Sareen J. An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes. BMC Psychiatry. 2019 May 3;19(1):132. doi: 10.1186/s12888-019-2124-5.
- Jacob KL, Christopher MS, Neuhaus EC. Development and validation of the cognitive-behavioral therapy skills questionnaire. Behav Modif. 2011 Nov;35(6):595-618. doi: 10.1177/0145445511419254. Epub 2011 Sep 5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2019:311
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
-
Linkoeping UniversityCompletedMajor Depressive DisorderSweden
-
The University of Texas Health Science Center at...TerminatedDepression | Major Depressive DisorderUnited States
-
Santa Casa Medical SchoolFaculdade de Ciências Médicas da Santa Casa de São PauloUnknownDepressive SymptomsBrazil
Clinical Trials on Cognitive Behavioural Therapy with Mindfulness classes
-
University of ManitobaCompletedDepression | PTSD | Anxiety Disorders | Stress Disorders, PosttraumaticCanada
-
Centre for Addiction and Mental HealthCompleted
-
Huichao ZhangRecruitingDepression, Anxiety | End-of-lifeChina
-
University of British ColumbiaCompleted
-
Mater Misericordiae University HospitalCompletedQuality of Life | Breast Cancer | Chronic Pain | Chronic Postsurgical PainIreland
-
Chinese University of Hong KongRecruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
University of British ColumbiaCompletedFemale Sexual DysfunctionCanada
-
University of BarcelonaCompletedDepression | Stress | Anxiety | Self Efficacy | Breast Cancer Female | HopefulnessTurkey
-
Karolinska InstitutetRegion StockholmActive, not recruiting
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaRecruiting